Back to Search Start Over

Predictors and Clinical Impact of Late Ventricular Arrhythmias in Patients With Continuous-Flow Left Ventricular Assist Devices.

Authors :
Galand V
Flécher E
Auffret V
Boulé S
Vincentelli A
Dambrin C
Mondoly P
Sacher F
Nubret K
Kindo M
Cardi T
Gaudard P
Rouvière P
Michel M
Gourraud JB
Defaye P
Chavanon O
Verdonk C
Ghodbane W
Pelcé E
Gariboldi V
Pozzi M
Obadia JF
Litzler PY
Anselme F
Babatasi G
Belin A
Garnier F
Bielefeld M
Hamon D
Radu C
Pierre B
Bourguignon T
Eschalier R
D'Ostrevy N
Bories MC
Marijon E
Vanhuyse F
Blangy H
Verhoye JP
Leclercq C
Martins RP
Source :
JACC. Clinical electrophysiology [JACC Clin Electrophysiol] 2018 Sep; Vol. 4 (9), pp. 1166-1175. Date of Electronic Publication: 2018 Jul 25.
Publication Year :
2018

Abstract

Objectives: This study aimed to evaluate the incidence, clinical impact, and predictors of late ventricular arrhythmias (VAs) in left ventricular assist device (LVAD) recipients aiming to clarify implantable cardioverter-defibrillator (ICD) indications.<br />Background: The arrhythmic risk and need for ICD in patients implanted with an LVAD are not very well known.<br />Methods: This observational study was conducted in 19 centers between 2006 and 2016. Late VAs were defined as sustained ventricular tachycardia or fibrillation occurring >30 days post-LVAD implantation, without acute reversible cause and requiring appropriate ICD therapy, external electrical shock, or medical therapy.<br />Results: Among 659 LVAD recipients, 494 (median 58.9 years of age; mean left ventricular ejection fraction 20.7 ± 7.4%; 73.1% HeartMate II, 18.6% HeartWare, 8.3% Jarvik 2000) were discharged alive from hospital and included in the final analysis. Late VAs occurred in 133 (26.9%) patients. Multivariable analysis identified 6 independent predictors of late VAs: VAs before LVAD implantation, atrial fibrillation before LVAD implantation, idiopathic etiology of the cardiomyopathy, heart failure duration >12 months, early VAs (<30 days post-LVAD), and no angiotensin-converting enzyme inhibitors during follow-up. The "VT-LVAD score" was created, identifying 4 risk groups: low (score 0 to 1), intermediate (score 2 to 4), high (score 5 to 6), and very high (score 7 to 10). The rates of VAs at 1 year were 0.0%, 8.0%, 31.0% and 55.0%, respectively.<br />Conclusions: Late VAs are common after LVAD implantation. The VT-LVAD score may help to identify patients at risk of late VAs and guide ICD indications in previously nonimplanted patients. (Determination of Risk Factors of Ventricular Arrhythmias [VAs] after implantation of continuous flow left ventricular assist device with continuous flow left ventricular assist device [CF-LVAD] [ASSIST-ICD]; NCT02873169).<br /> (Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
2405-5018
Volume :
4
Issue :
9
Database :
MEDLINE
Journal :
JACC. Clinical electrophysiology
Publication Type :
Academic Journal
Accession number :
30236390
Full Text :
https://doi.org/10.1016/j.jacep.2018.05.006